We are live on ! Find out more
OHS

Odey Holdings (Switzerland) Portfolio holdings

AUM $11.1M
1-Year Est. Return 64.12%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+64.12%
3 Year Est. Return
+103.95%
5 Year Est. Return
+271.11%
10 Year Est. Return
AUM
$7.98M
AUM Growth
+$6.55M
Cap. Flow
+$5.72M
Cap. Flow %
71.65%
Top 10 Hldgs %
95.59%
Holding
29
New
5
Increased
Reduced
5
Closed
10

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$64.8K
2
GS icon
Goldman Sachs
GS
+$38.6K
3
SCHW
Charles Schwab
SCHW
+$31.6K
4
B
Barrick Mining
B
+$22.2K

Top Sells

Rank Stock Value
1
CME icon
CME Group
CME
+$81K
2
TXN icon
Texas Instruments
TXN
+$63K
3
COST icon
Costco
COST
+$61K
4
HD icon
Home Depot
HD
+$60K
5
BAC icon
Bank of America
BAC
+$57K

Sector Composition

Rank Sector Weight
1 Financials 3.4%
2 Communication Services 2.43%
3 Healthcare 2.27%
4 Consumer Discretionary 1.7%
5 Technology 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
26
Home Depot
HD
$331B
-350
Closed -$60K
TRIP icon
27
TripAdvisor
TRIP
$1.65B
-1,000
Closed -$54K
TXN icon
28
Texas Instruments
TXN
$252B
-670
Closed -$63K
ATVI
29
DELISTED
Activision Blizzard
ATVI
-1,100
Closed -$51K

Similar funds

Odey Holdings (Switzerland)'s Q1 2019 Portfolio in Review

As of Q1 2019, Odey Holdings (Switzerland) held 29 positions worth $7.98M, up 458% from $1.43M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Odey Holdings (Switzerland) deployed $5.72M of net new capital in Q1 2019, opening 5 new positions. Its largest new stake was Bristol-Myers Squibb: 1,300 shares worth $62K.

By sector, the portfolio is most concentrated in Financials at 3.4% of assets, down from 26% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $41.2K trimmed.

  • Odey Holdings (Switzerland)'s largest Q1 2019 buy was Bristol-Myers Squibb: 1,300 shares worth $62K.
  • Odey Holdings (Switzerland)'s biggest Q1 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $41.2K.
  • Odey Holdings (Switzerland) fully exited CME Group in Q1 2019, selling an estimated $81K.
  • Odey Holdings (Switzerland)'s ten largest holdings make up 96% of its $7.98M portfolio in Q1 2019.
  • Odey Holdings (Switzerland) opened 5 new positions and closed 10 in Q1 2019.
  • Odey Holdings (Switzerland)'s portfolio value rose 458% quarter-over-quarter to $7.98M.

Based on Odey Holdings (Switzerland)'s 13F filing for Q1 2019, filed 15 May 2019.